Akonni Biosystems has announced that it will participate at the 2010 OneMedForum on Tuesday, January 12. The conference will be held at the St. Francis Drake Hotel in Sand Francisco, California. Akonni CEO Charles Daitch, PhD will be delivering the company’s presentation. He will begin speaking at 4:15 pm in Room 313/Mezzanine Level. There will a forty minute break out session following the conclusion of his presentation. For more information regarding the event, contact Kevin Banks, PhD at 301.698.0101 x232. He may also be reached by email at kbanks@akonni.com.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Akonni Biosystems was founded in 2003 and has over 20 patents issued with 13 others pending. The company’s core technology is based on work developed at Argonne National Laboratory and the Engelhardt Institute of Molecular Biology and utilizes gel-drop array technologies optimized for developing medical applications. Supported by a series of government grants and contracts from NIH, CDC, DOE, DOD, NIJ, and NSF, the company has significantly advanced the original technology by improving the system’s capabilities from sample preparation to final result. Products in its near-term pipeline include multiplex panel assays for detecting multidrug-resistant tuberculosis, upper respiratory infections, encephalitis, and hospital-acquired infections.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
